Table 4.
Inferential examples | Age (years) | Grade | Metastasis | Size (cm) | Mortality risk |
---|---|---|---|---|---|
1 | < 14 | High | None | < 7 | 1.5% |
2 | 14–23 | High | None | < 7 | 1.8% |
3 | 24–51 | High | None | < 7 | 2.2% |
4 | > 51 | High | None | < 7 | 7.7% |
5 | 24–51 | Intermediate | None | < 7 | 2.3% |
6 | > 51 | Intermediate | None | < 7 | 5.8% |
7 | 24–51 | Low | None | < 7 | 0.3% |
8 | > 51 | Low | None | < 7 | 0.7% |
9 | 14–23 | High | Yes | < 7 | 6.6% |
10 | < 14 | High | None | 7–9.9 | 3.6% |
11 | 14–23 | High | None | 7–9.9 | 4.5% |
12 | 24–51 | High | None | 7–9.9 | 5.4% |
13 | > 51 | High | None | 7–9.9 | 17.3% |
14 | 24–51 | Low | None | 7–9.9 | 0.8% |
15 | > 51 | Low | None | 7–9.9 | 1.6% |
16 | < 14 | High | Yes | 7–9.9 | 12.4% |
17 | 14–23 | High | Yes | 7–9.9 | 15.0% |
18 | 24–51 | High | Yes | 7–9.9 | 17.6% |
19 | > 51 | High | Yes | 7–9.9 | 44.0% |
20 | < 14 | High | None | 10–15 | 4.4% |
21 | 14–23 | High | None | 10–15 | 5.5% |
22 | 24–51 | High | None | 10–15 | 6.6% |
23 | > 51 | High | None | 10–15 | 20.6% |
24 | > 51 | Intermediate | None | 10–15 | 16.0% |
25 | 24–51 | Low | None | 10–15 | 1.0% |
26 | > 51 | Low | None | 10–15 | 2.0% |
27 | < 14 | High | Yes | 10–15 | 14.8% |
28 | 14–23 | High | Yes | 10–15 | 17.9% |
29 | 24–51 | High | Yes | 10–15 | 20.9% |
30 | > 51 | High | Yes | 10–15 | 49.2% |
31 | < 14 | High | None | > 15 | 8.0% |
32 | 14–23 | High | None | > 15 | 9.8% |
33 | 24–51 | High | None | > 15 | 11.6% |
34 | > 51 | High | None | > 15 | 32.6% |
35 | > 51 | Intermediate | None | > 15 | 26.2% |
36 | 24–51 | Low | None | > 15 | 1.9% |
37 | > 51 | Low | None | > 15 | 3.7% |
38 | 14–23 | High | Yes | > 15 | 29.0% |
39 | 24–51 | High | Yes | > 15 | 33.0% |
40 | > 51 | High | Yes | > 15 | 64.0% |
Estimates of probability ranged from 0.3% to 64.4%; examples with a case probability > 0.5% from the 120 inferential variations are presented, these describe the relationship of each interdependent feature and the likelihood of death within 1 year of diagnosis.